| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $142K | -98.4% |
| Cost of Revenue | $83K | -82.2% |
| Gross Profit | $58K | -99.3% |
| R&D Expense | $1.4M | +98.0% |
| SG&A Expense | $26.6M | +54.5% |
| Operating Income | -$84.1M | -2613.7% |
| Interest Expense | $64K | -91.6% |
| Income Tax | $15K | -79.4% |
| Net Income | -$47.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.7M | +1679.9% |
| Accounts Receivable | $85K | +60.2% |
| Inventory | $7.5M | +1.1% |
| Current Assets | $14.9M | — |
| Total Assets | $21.1M | -40.9% |
| Current Liabilities | $20.1M | +160.3% |
| Long-term Debt | $12.8M | -46.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.6M | -2308.6% |
| Capital Expenditures | $46K | +32.1% |
| Investing Cash Flow | -$265K | -100.1% |
| Financing Cash Flow | $21.6M | +107.4% |
| Free Cash Flow | -$25.6M | -2236.1% |
| — |
| EPS (Basic) | -$1.88 | -93.8% |
| EPS (Diluted) | -$1.88 | -93.8% |
| Total Liabilities |
| $38.1M |
| +306.4% |
| Stockholders' Equity | -$17.0M | -84.4% |